Gamma Glutamyl Transferase as A Marker of Metabolic Syndrome

Abstract

In an era of a cardiovascular epidemic an imminent search has been sought for more sensitive and specific markers of sub-clinical inflammation, thermogenesis, and increased adiposity. This study attempts to assess how serum Gamma Glutamyl Transferase [GGT] performed as an ideal endogenous substance for the diagnosis of metabolic syndrome and hence estimate cardiovascular risk.